Moderna (MRNA) Income from Continuing Operations (2017 - 2026)
Moderna (MRNA) reported Income from Continuing Operations of -$782 million for Q2 2026, compared with -$825 million a year earlier.
Powered by 
Analysis
Moderna (MRNA) Income from Continuing Operations (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Moderna's Income from Continuing Operations came in at -$3.15 billion; for FY2025, it came in at -$2.82 billion.
- By year, Income from Continuing Operations came in at -$3.56 billion in FY2024, -$4.71 billion in FY2023, $8.36 billion in FY2022 (-31.5%) and $12.2 billion in FY2021.
- Five-year quarterly Income from Continuing Operations spans a low of -$3.63 billion in Q3 2023 and a high of $4.87 billion in Q4 2021.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$1.34 billion (Q1 2026), -$826 million (Q4 2025) and -$200 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Moderna | 100.92 Bn | 80.27 Bn | 52.00 Mn | -782.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -782.00 Mn |
| Mar 31, 2026 | -1.34 Bn |
| Dec 31, 2025 | -826.00 Mn |
| Sep 30, 2025 | -200.00 Mn |
| Jun 30, 2025 | -825.00 Mn |
| Mar 31, 2025 | -971.00 Mn |
| Dec 31, 2024 | -1.12 Bn |
| Sep 30, 2024 | 13.00 Mn |
| Jun 30, 2024 | -1.28 Bn |
| Mar 31, 2024 | -1.18 Bn |
| Dec 31, 2023 | 217.00 Mn |
| Sep 30, 2023 | -3.63 Bn |
| Jun 30, 2023 | -1.38 Bn |
| Mar 31, 2023 | 79.00 Mn |
| Dec 31, 2022 | 1.47 Bn |
| Sep 30, 2022 | 1.04 Bn |
| Jun 30, 2022 | 2.20 Bn |
| Mar 31, 2022 | 3.66 Bn |
| Dec 31, 2021 | 4.87 Bn |
| Sep 30, 2021 | 3.33 Bn |
API Access
Moderna Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=MRNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();